PlayOn11 - Where Fans Become Winners
Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy

The drugmaker Erasca said Monday that its RAS-targeting pill shrank tumors in 40% of patients with a...

BUSINESS NEWS April 27, 2026

Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy

The drugmaker Erasca said Monday that its RAS-targeting pill shrank tumors in 40% of patients with advanced pancreatic cancer and 62% of patients with...

1 views 0 likes 0 comments
The drugmaker Erasca said Monday that its RAS-targeting pill shrank tumors in 40% of patients with advanced pancreatic cancer and 62% of patients with...

Author: statnews.com

Read Original Article

Related News

Advertisement
Ads with us
Advertisement

Top Categories

Advertisement
Ads with us
Advertisement
Ads with us
Advertisement
Ads with us
Advertisement
Ads with us